Microbix Biosystems Inc.
MBXBF · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -47.5% | 53.8% | -13.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 53% | 60.6% | 45.3% | 58.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 2.3% | 24.4% | 11.9% | 17.4% |
| Net Income | -$0 | $0 | -$0 | $0 |
| % Margin | -12.1% | 13.9% | -0.2% | 9.4% |
| EPS Diluted | -0.012 | 0.026 | -0 | 0.013 |
| % Growth | -145.3% | 8,633.3% | -102.4% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |